Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients
Crossref DOI link: https://doi.org/10.1007/s40262-017-0555-z
Published Online: 2017-05-24
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Klopp-Schulze, Lena
Joerger, Markus
Wicha, Sebastian G.
ter Heine, Rob
Csajka, Chantal
Parra-Guillen, Zinnia P.
Kloft, Charlotte
License valid from 2017-05-24